卵胞浆内单精子显微注射技术在男性不育症中的临床应用  

Clinical application of intracytoplamic sperm injection in treating male infitility

作　　者：朱健生[1] 季钢[1] 张玲[1] 洪名云[1] 王朝红[1] 姚桂东[1] 

机构地区：[1]合肥市妇幼保健院,安徽230001

出　　处：《中国优生与遗传杂志》2008年第9期106-107,共2页Chinese Journal of Birth Health & Heredity

摘　　要：目的探讨卵胞浆内单精子显微注射(ICSI)技术治疗男性因素不育的临床效果。方法对45例男性因素不育症患者共计53个ICSI治疗周期进行了回顾性的分析。结果53个ICSI治疗周期共取卵535个,MⅡ期卵母细胞423个,MⅡ期卵母细胞正常受精率82.3%,卵裂率89.1%,临床妊娠16例,周期临床妊娠率为30.2%。结论对男性因素不育症患者ICSI是一种有效的治疗方法。Objective： To study the clinical effect of intracytoplasmic sperm injection （ICSI） in male infitility. Methods： 53 ICSI treatment cycles in male infertility were reviewed. Results ： In 53 treatment cycles, 535 oocytes were obtained, among which 423 were in metaphase Ⅱ（MⅡ ） . The normal fertilization rate of MⅡ oocytes was 82. 3%, the cleavage rate was 89. 1%. There were 16 cases achieved clinical pregnancy and the rate was 30. 2% per cycle. Conclusion： ICSI is an effective method in male infitility.

关 键 词：男性不育 卵胞浆内单精子显微注射(ICSI) 胚胎移植 妊娠 

分 类 号：R698.2[医药卫生—泌尿科学]